Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cytokine-Based Immunotherapy Following High-Dose Chemotherapy and Autologous Stem Cell Transplantation

NCT00003408 is registered in ClinicalTrials.gov with Cancer Treatment Centers of America as lead sponsor.

NCT NCT00003408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cytokine-Based Immunotherapy Following High-Dose Chemotherapy and Autologous Stem Cell Transplantation
Lead sponsor
Cancer Treatment Centers of America
Phase
Phase 2
Overall status
Completed
Start date
April 30, 1998
Completion date
March 31, 2000
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, chronic myeloproliferative disorders, gestational trophoblastic tumor, kidney cancer, leukemia, lymphoma, multiple myeloma and plasma cell neoplasm, myelodysplastic syndromes, neuroblastoma, ovarian cancer, sarcoma, testicular germ cell tumor